Rinki Murphy1, Peter Tsai2, Mia Jüllig3, Amy Liu4, Lindsay Plank5, Michael Booth6. 1. Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Private Bag, Auckland, 92019, New Zealand. R.Murphy@auckland.ac.nz. 2. Department of Bioinformatics, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. 3. School of Biological Sciences, University of Auckland, Auckland, New Zealand. 4. Auckland Diabetes Centre, Greenlane Clinical Centre, Auckland, New Zealand. 5. Department of Surgery, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. 6. Department of Surgery, North Shore Hospital, Auckland, New Zealand.
Abstract
BACKGROUND: It is unclear whether specific gut microbiota is associated with remission of type 2 diabetes (T2D) after distinct types of bariatric surgery. AIMS: The aim of this study is to examine gut microbiota changes after laparoscopic Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) surgery in obese patients with T2D. METHODS: Whole-metagenome shotgun sequencing of DNA fragments using Illumina HiSeq2000 was obtained from stool samples collected from 14 obese T2D patients pre-operatively (while on very low calorie diet) and 1 year after randomisation to laparoscopic SG (n = 7) or RYGB (n = 7). Resulting shotgun reads were annotated with Kyoto Encyclopedia of Genes and Genomes (KEGG). RESULTS:Body weight reduction and dietary change was similar 1 year after both surgery types. Identical proportions (n = 5/7) achieved diabetes remission (HbA1c < 48 mmol/mol without medications) 1 year after RYGB and SG. RYGB resulted in increased Firmicutes and Actinobacteria phyla but decreased Bacteroidetes phyla. SG resulted in increased Bacteroidetes phyla. Only an increase in Roseburia species was observed among those achieving diabetes remission, common to both surgery types. KEGG Orthology and pathway analysis predicted contrasting and greater gut microbiota metabolism changes after diabetes remission following RYGB than after SG. Those with persistent diabetes post-operatively had higher Desulfovibrio species pre-operatively. CONCLUSIONS: Overall, RYGB produces greater and more predicted favourable changes in gut microbiota functional capacity than SG. An increase in Roseburia species was the only compositional change common to both types of surgery among those achieving diabetes remission.
RCT Entities:
BACKGROUND: It is unclear whether specific gut microbiota is associated with remission of type 2 diabetes (T2D) after distinct types of bariatric surgery. AIMS: The aim of this study is to examine gut microbiota changes after laparoscopic Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) surgery in obesepatients with T2D. METHODS: Whole-metagenome shotgun sequencing of DNA fragments using Illumina HiSeq2000 was obtained from stool samples collected from 14 obese T2D patients pre-operatively (while on very low calorie diet) and 1 year after randomisation to laparoscopic SG (n = 7) or RYGB (n = 7). Resulting shotgun reads were annotated with Kyoto Encyclopedia of Genes and Genomes (KEGG). RESULTS: Body weight reduction and dietary change was similar 1 year after both surgery types. Identical proportions (n = 5/7) achieved diabetes remission (HbA1c < 48 mmol/mol without medications) 1 year after RYGB and SG. RYGB resulted in increased Firmicutes and Actinobacteria phyla but decreased Bacteroidetes phyla. SG resulted in increased Bacteroidetes phyla. Only an increase in Roseburia species was observed among those achieving diabetes remission, common to both surgery types. KEGG Orthology and pathway analysis predicted contrasting and greater gut microbiota metabolism changes after diabetes remission following RYGB than after SG. Those with persistent diabetes post-operatively had higher Desulfovibrio species pre-operatively. CONCLUSIONS: Overall, RYGB produces greater and more predicted favourable changes in gut microbiota functional capacity than SG. An increase in Roseburia species was the only compositional change common to both types of surgery among those achieving diabetes remission.
Authors: Carlotta De Filippo; Duccio Cavalieri; Monica Di Paola; Matteo Ramazzotti; Jean Baptiste Poullet; Sebastien Massart; Silvia Collini; Giuseppe Pieraccini; Paolo Lionetti Journal: Proc Natl Acad Sci U S A Date: 2010-08-02 Impact factor: 11.205
Authors: Alan W Walker; Jennifer Ince; Sylvia H Duncan; Lucy M Webster; Grietje Holtrop; Xiaolei Ze; David Brown; Mark D Stares; Paul Scott; Aurore Bergerat; Petra Louis; Freda McIntosh; Alexandra M Johnstone; Gerald E Lobley; Julian Parkhill; Harry J Flint Journal: ISME J Date: 2010-08-05 Impact factor: 10.302
Authors: Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon Journal: Proc Natl Acad Sci U S A Date: 2004-10-25 Impact factor: 11.205
Authors: J Graessler; Y Qin; H Zhong; J Zhang; J Licinio; M-L Wong; A Xu; T Chavakis; A B Bornstein; M Ehrhart-Bornstein; V Lamounier-Zepter; T Lohmann; T Wolf; S R Bornstein Journal: Pharmacogenomics J Date: 2012-10-02 Impact factor: 3.550
Authors: John B Buse; Sonia Caprio; William T Cefalu; Antonio Ceriello; Stefano Del Prato; Silvio E Inzucchi; Sue McLaughlin; Gordon L Phillips; R Paul Robertson; Francesco Rubino; Richard Kahn; M Sue Kirkman Journal: Diabetes Care Date: 2009-11 Impact factor: 19.112
Authors: Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis Journal: Science Date: 2011-09-01 Impact factor: 47.728
Authors: Renuka Subramaniam; Hassan Aliakbarian; Hina Y Bhutta; David A Harris; Ali Tavakkoli; Eric G Sheu Journal: Obes Surg Date: 2019-12 Impact factor: 4.129
Authors: ThucNhi T Dang; Jerry T Dang; Muhammad Moolla; Noah Switzer; Karen Madsen; Daniel W Birch; Shahzeer Karmali Journal: Obes Surg Date: 2019-06 Impact factor: 4.129
Authors: Jacob J Patz; Melissa C Helm; Rana M Higgins; Matthew I Goldblatt; Jon C Gould; Tammy L Kindel Journal: Surg Endosc Date: 2019-02-07 Impact factor: 4.584
Authors: Jacob G Mabey; John M Chaston; Daphne G Castro; Ted D Adams; Steven C Hunt; Lance E Davidson Journal: Surg Obes Relat Dis Date: 2020-04-18 Impact factor: 4.734
Authors: S Sherf-Dagan; S Zelber-Sagi; G Zilberman-Schapira; M Webb; A Buch; A Keidar; A Raziel; N Sakran; D Goitein; N Goldenberg; J A Mahdi; M Pevsner-Fischer; N Zmora; M Dori-Bachash; E Segal; E Elinav; O Shibolet Journal: Int J Obes (Lond) Date: 2017-08-30 Impact factor: 5.095